Skip to main content

$0.330 0.010 (3.13%)

High

$0.34

Low

$0.31

Trades

12

Turnover

$48,258

Volume

147,149
30 June 2023 at 2:58pm
Register to track IMR and receive email alerts.
Subject
IMR Ann: Imricor to Present at NWR Virtual Conference

IMR Ann: Appendix 4C - Quarterly Report and Business Update

IMR Ann: Updated Corporate Goverance Statement

IMR Ann: Letter to Shareholders and Online Meeting Guide

IMR Ann: Notice of Annual Stockholders Meeting and CDI Voting Form

IMR Ann: Appendix 4G and Corporate Governance Statement

IMR Ann: Annual Report to shareholders

IMR Ann: Imricor Adds 15th Site and First in Italy

IMR Ann: Change of Director's Interest Notice

IMR Ann: S&P DJI Announces March 2022 Quarterly Rebalance

IMR Ann: Application for quotation of securities - IMR

IMR Ann: FY21 Results Investor Presentation

IMR Ann: Imricor Releases FY21 Results

IMR Ann: Appendix 4E and FY21 Financial Accounts

IMR Ann: Munster University Hospital Performs First iCMR Procesure

IMR Ann: Leadership Team Update

IMR Ann: Details of FY21 Results Investor Briefing

IMR Ann: Appendix 4C - Quarterly Report and Business Update

IMR Ann: Upcoming Investor Conference Call for Dec Quarterly Report

IMR Ann: Change in substantial holding

IMR Ann: Imricor Adds Fourteenth Site and First in Greece

IMR Ann: Imricor Enrolls Two More Sites in Berlin

IMR Ann: Strategic Investment in MiRTLE Medical

IMR Ann: Application for FDA Investigational Device Exemption

IMR Ann: Appendix 4C - Quarterly Report and Business Update

IMR Ann: Becoming a substantial holder

IMR Ann: Supplementary Disclosure on Semmelweis Purchase Agreement

IMR Ann: Application for quotation of securities - IMR

IMR Ann: New Lab Adoption at Semmelweis University in Hungary

IMR Ann: Imricor Completes SPP

IMR Ann: MiRTLE Sales Agreement Clarification and Business Update

IMR Ann: Imricor Signs Sales Agreement with MiRTLE Medical

IMR Ann: Change in Substantial Holding

IMR Ann: Becoming a substantial holder

IMR Ann: Security Purchase Plan Booklet Sent to Eligible Holders

IMR Ann: Cleansing Notice

IMR Ann: Response to ASX Query

IMR Ann: Change in substantial holding

IMR Ann: Application for quotation of securities - IMR

IMR Ann: Investor Presentation

IMR Ann: Proposed issue of securities - IMR

IMR Ann: Proposed issue of securities - IMR

IMR Ann: Successful Completion of Placement and Launch of SPP

IMR Ann: Trading Halt

IMR Ann: Application for quotation of securities - IMR

IMR Ann: Imricor Signs Sales Agreement with NordicNeuroLab

IMR Ann: HY21 Investor Presentation

IMR Ann: Imricor releases Half Year Results for 1H 2021

IMR Ann: Appendix 4D and Half Year Report & Accounts

IMR Ann: Upcoming Release from Escrow Notification

Register to track IMR and receive email alerts.